{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:46:23Z","timestamp":1793778383744,"version":"4.6.1"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011841","name":"Xinxiang Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011841","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.diabres.2022.110201","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:26:18Z","timestamp":1670329578000},"page":"110201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Bone marrow-derived mesenchymal stem cells: A promising therapeutic option for the treatment of diabetic foot ulcers"],"prefix":"10.1016","volume":"195","author":[{"given":"Ganesh","family":"Dama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2022.110201_b0005","unstructured":"Diabetes atlas. 6th ed. International Diabetes Federation 2013."},{"key":"10.1016\/j.diabres.2022.110201_b0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2022.110201_b0015","unstructured":"International Diabetes Federation. The global burden. IDF diabetes atlas. 5th. ed. 2012."},{"key":"10.1016\/j.diabres.2022.110201_b0020","first-page":"103","article-title":"Diabetic foot ulcers: etiology, treatment and prevention","volume":"37","author":"Grunfeld","year":"1992","journal-title":"Adv Intern Med"},{"key":"10.1016\/j.diabres.2022.110201_b0025","series-title":"Principle of internal medicine","first-page":"830","article-title":"Diabetes mellitus","author":"Alvin","year":"2005"},{"key":"10.1016\/j.diabres.2022.110201_b0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clindermatol.2006.09.015","article-title":"The diabetic foot","volume":"25","author":"Rathur","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.diabres.2022.110201_b0035","unstructured":"Boulton AJM, Whitehouse RW. The Diabetic Foot. In Endotext; Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K, Grossman A, Hershman JM, Hofland J et al, Eds.; MDText.com, Inc.: South Dartmouth, MA, USA, 2000."},{"key":"10.1016\/j.diabres.2022.110201_b0040","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/(SICI)1096-9136(199611)13:11<967::AID-DIA266>3.0.CO;2-K","article-title":"Increased mortality associated with diabetic foot ulcer","volume":"13","author":"Boyko","year":"1996","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2022.110201_b0045","first-page":"737","article-title":"Management of ischemic diabetic foot","volume":"54","author":"Caravaggi","year":"2013","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.diabres.2022.110201_b0050","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2337\/diacare.22.3.382","article-title":"Incidence, outcomes and costs of foot ulcers in patients with diabetes","volume":"22","author":"Ramsey","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.110201_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/S0958-2592(97)90025-0","article-title":"Morbidity and mortality associated with diabetic foot disease: a 12-month prospective survey of hospital admissions in a single UK centre","volume":"7","author":"Krentz","year":"1997","journal-title":"Foot"},{"key":"10.1016\/j.diabres.2022.110201_b0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1534734604267677","article-title":"An audit of lower extremity complications in octogenarian patients with diabetes mellitus","volume":"3","author":"Reed","year":"2004","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.diabres.2022.110201_b0065","doi-asserted-by":"crossref","first-page":"9328347","DOI":"10.1155\/2017\/9328347","article-title":"Mesenchymal Stem Cells Improve Healing of Diabetic Foot Ulcer","volume":"2017","author":"Cao","year":"2017","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.diabres.2022.110201_b0070","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1634\/stemcells.2007-0226","article-title":"Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis","volume":"25","author":"Wu","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.diabres.2022.110201_b0075","first-page":"134","article-title":"Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot","volume":"27","author":"Vojtass\u00e1k","year":"2006","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.diabres.2022.110201_b0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.diabres.2011.12.011","article-title":"Progress in stem cell therapy for the diabetic foot","volume":"97","author":"Jiang","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2022.110201_b0085","doi-asserted-by":"crossref","DOI":"10.1007\/s00441-012-1393-9","article-title":"Mechanisms of action of mesenchymal stem cells in cutaneous wound repair and regeneration","volume":"348","author":"Li","year":"2012","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.diabres.2022.110201_b0090","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3727\/096368909788534942","article-title":"Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease","volume":"18","author":"Amann","year":"2009","journal-title":"Cell Transplant"},{"key":"10.1016\/j.diabres.2022.110201_b0095","first-page":"173","article-title":"Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot","volume":"55","author":"Proch\u00e1zka","year":"2009","journal-title":"Vnitr Lek"},{"key":"10.1016\/j.diabres.2022.110201_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(05)67698-2","article-title":"The global burden of diabetic foot disease","volume":"366","author":"Boulton","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2022.110201_b0105","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/qjmed\/hcn027","article-title":"The diabetic foot","volume":"101","author":"Khanolkar","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.diabres.2022.110201_b0110","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.2337\/diab.46.2.S58","article-title":"The pathogenesis of diabetic foot problems. An overview","volume":"46","author":"Shaw","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.110201_b0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.foot.2010.10.003","article-title":"Clinico-microbial study and anti-microbial drug resistance profile of diabetic foot infections in North India","volume":"21","author":"Zubair","year":"2011","journal-title":"Foot"},{"key":"10.1016\/j.diabres.2022.110201_b0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/WCO.0b013e32830b84cb","article-title":"Diabetic polyneuropathy: an update","volume":"21","author":"Zochodone","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.diabres.2022.110201_b0125","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/BF00400653","article-title":"Comparison of the effects of ascorbylm- linolenic acid and m-linolenic acid in the correction of neurovascular deficits in diabetic rats","volume":"39","author":"Cameron","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.110201_b0130","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2337\/diab.43.9.1122","article-title":"Characterization of the mechanisms for the chronic activation of diacylglycerol-protein kinase C pathways in diabetes and hypergalactosemia","volume":"43","author":"Xia","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.110201_b0135","doi-asserted-by":"crossref","unstructured":"Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev. 1998; 14:241\u201319.https:\/\/doi.org\/10.1002\/(sici)1099-0895(1998090)14:3<241::aid dmr216>3.0.co;2-r.","DOI":"10.1002\/(SICI)1099-0895(1998090)14:3<241::AID-DMR216>3.0.CO;2-R"},{"key":"10.1016\/j.diabres.2022.110201_b0140","first-page":"271","article-title":"Nerve growth factor and diabetic neuropathy","volume":"4","author":"Pittenger","year":"2003","journal-title":"Exp Diabesity Res"},{"key":"10.1016\/j.diabres.2022.110201_b0145","first-page":"371","article-title":"Autoimmunity and diabetic neuropathy","volume":"4","author":"Canal","year":"1997","journal-title":"Clin Neurosci"},{"key":"10.1016\/j.diabres.2022.110201_b0150","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.110201_b0155","series-title":"Chronic wound care: a clinical source book for healthcare professionals","first-page":"575","article-title":"Diabetic wounds, assessment, classification, and management","author":"Steed","year":"2001"},{"key":"10.1016\/j.diabres.2022.110201_b0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1099800408319056","article-title":"Wound bioburden and infection-related complications in diabetic foot ulcers","volume":"10","author":"Gardner","year":"2008","journal-title":"Biol Res Nurs"},{"key":"10.1016\/j.diabres.2022.110201_b0165","first-page":"52","article-title":"A review of pathophysiology, classification and treatment of foot ulcers in diabetic patients. Clin","volume":"27","author":"Clayton","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.110201_b0170","first-page":"362","article-title":"Lower Extremity Peripheral Artery Disease: Diagnosis and Treatment","volume":"99","author":"Firnhaber","year":"2019","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.diabres.2022.110201_b0175","doi-asserted-by":"crossref","DOI":"10.1038\/ncpcardio0823","article-title":"Therapy insight : peripheral arterial disease and diabetes : from pathogenesis to treatment guidelines","volume":"4","author":"Mohler","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.diabres.2022.110201_b0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1086\/383267","article-title":"Diagnosing foot infection in diabetes","volume":"39","author":"Williams","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabres.2022.110201_b0185","first-page":"341","article-title":"Infections of diabetic foot ulcer. Eur","volume":"14","author":"Candel Gonzalez","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.diabres.2022.110201_b0190","doi-asserted-by":"crossref","DOI":"10.2337\/db12-0771","article-title":"The neuropathic diabetic foot ulcer microbiome is associated with clinical factors","volume":"62","author":"Gardner","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.110201_b0195","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0891-5520(20)30354-8","article-title":"The diabetic foot: soft tissue and bone infection","volume":"4","author":"Lipsky","year":"1990","journal-title":"Infect Dis Clin N Am"},{"key":"10.1016\/j.diabres.2022.110201_b0200","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1464-5491.2003.00860.x","article-title":"Methicillin resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem","volume":"20","author":"Dang","year":"2003","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2022.110201_b0205","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1464-5491.1992.tb01885.x","article-title":"Foot infections in diabetes are rarely due to a single microorganism","volume":"9","author":"Hunt","year":"1992","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2022.110201_b0210","article-title":"Foot infections in patients with diabetes","volume":"56","author":"Caputo","year":"1997","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.diabres.2022.110201_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjsurg.2003.10.008","article-title":"An evidence based approach to diabetic foot infection","volume":"186","author":"Frykberg","year":"2003","journal-title":"Am J Surg"},{"key":"10.1016\/j.diabres.2022.110201_b0220","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1534734605280130","article-title":"A review of the mechanisms implicated in the pathogenesis of the diabetic foot","volume":"4","author":"Dinh","year":"2005","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.diabres.2022.110201_b0225","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/S0140-6736(03)14917-3","article-title":"Factors that precipitate development of diabetic foot ulcers in rural India","volume":"362","author":"Aleem","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2022.110201_b0230","doi-asserted-by":"crossref","unstructured":"Murray HJ, Young MJ, Boulton AJ. The relationship between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med. 1996; 13:979\u201382.https:\/\/doi.org\/0.1002\/(SICI)1096-9136(199611)13:11<979::AID-DIA267>3.0.CO;2-A.","DOI":"10.1002\/(SICI)1096-9136(199611)13:11<979::AID-DIA267>3.3.CO;2-1"},{"key":"10.1016\/j.diabres.2022.110201_b0235","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/bmj.326.7396.977","article-title":"The diabetic foot","volume":"326","author":"Watkins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2022.110201_b0240","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/iwj.12496","article-title":"The 2015 IWGDF guidance on the prevention and management of foot problems in diabetes","volume":"13","author":"Bakker","year":"2016","journal-title":"Int Wound J"},{"key":"10.1016\/j.diabres.2022.110201_b0245","first-page":"117","article-title":"Classification, diagnosis, and treatment of diabetic foot ulcers","volume":"20","author":"Doupis","year":"2008","journal-title":"Wounds"},{"key":"10.1016\/j.diabres.2022.110201_b0250","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/dmrr.854","article-title":"Specific guidelines on wound and wound-bed management","volume":"24","author":"Hinchliffe","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabres.2022.110201_b0255","doi-asserted-by":"crossref","DOI":"10.1111\/j.1464-5491.2008.02573.x","article-title":"Unresolved issues in the management of ulcers of the foot in diabetes","author":"Jeffcoate","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2022.110201_b0260","doi-asserted-by":"crossref","DOI":"10.1634\/stemcells.22-5-649","article-title":"Human placenta-derived cells have mesenchymal stem\/progenitor cell potential","author":"Fukuchi","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.diabres.2022.110201_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2008.09.009","article-title":"Human fetal membranes: a source of stem cells for tissue regeneration and repair?","volume":"30","author":"Ilancheran","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.diabres.2022.110201_b0270","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s13287-018-1078-8","article-title":"Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review","volume":"9","author":"Christodoulou","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.diabres.2022.110201_b0275","article-title":"The dynamic roles of mesenchymal stem cells in colon cancer. Can","author":"Wang","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2022.110201_b0280","article-title":"Enhancement of functionality and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for cardiovascular disease","volume":"20","author":"Yun","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2022.110201_b0285","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/sctm.17-0210","article-title":"Concise review: rational use of mesenchymal stem cells in the treatment of ischemic heart disease","volume":"7","author":"Ward","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.diabres.2022.110201_b0290","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201410-1765OC","article-title":"Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice","volume":"192","author":"Monsel","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.diabres.2022.110201_b0295","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13287-017-0669-0","article-title":"Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension","volume":"8","author":"Mendon\u00e7a","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.diabres.2022.110201_b0300","doi-asserted-by":"crossref","DOI":"10.1089\/scd.2010.0140","article-title":"Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide","author":"Mosna","year":"2010","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.diabres.2022.110201_b0305","article-title":"Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue. World","author":"Vellasamy","year":"2012","journal-title":"J Stem Cells"},{"key":"10.1016\/j.diabres.2022.110201_b0310","doi-asserted-by":"crossref","unstructured":"Batsali AK, Kastrinaki MC, Papadaki HA, Pontikoglou C. Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications. Curr Stem Cell Res Ther. 2013; 8: 144\u201355.https:\/\/doi.org\/10.2174\/1574888x11308020005.","DOI":"10.2174\/1574888X11308020005"},{"key":"10.1016\/j.diabres.2022.110201_b0315","doi-asserted-by":"crossref","DOI":"10.1111\/j.1524-475X.2007.00221.x","article-title":"Bone marrow-derived stem cells in wound healing: a review","author":"Wu","year":"2007","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.diabres.2022.110201_b0320","doi-asserted-by":"crossref","DOI":"10.1007\/s00441-008-0724-3","article-title":"Mesenchymal stem cells and skin wound repair and regeneration: possibilities and questions","author":"Fu","year":"2009","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.diabres.2022.110201_b0325","doi-asserted-by":"crossref","DOI":"10.1634\/stemcells.22-5-812","article-title":"Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair","volume":"22","author":"Fathke","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.diabres.2022.110201_b0330","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1189\/jlb.69.4.513","article-title":"Chemokines in cutaneous wound healing","volume":"69","author":"Gillitzer","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.diabres.2022.110201_b0335","doi-asserted-by":"crossref","DOI":"10.1186\/ar2116","article-title":"Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation","author":"Kolf","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.diabres.2022.110201_b0340","doi-asserted-by":"crossref","DOI":"10.1634\/stemcells.2004-0183","article-title":"In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions","author":"Ishii","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.diabres.2022.110201_b0345","doi-asserted-by":"crossref","DOI":"10.1089\/ten.2005.11.110","article-title":"Engrafted bone marrow-derived flk-(1) mesenchymal stem cells regenerate skin tissue","author":"Deng","year":"2005","journal-title":"Tissue Eng"},{"key":"10.1016\/j.diabres.2022.110201_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2004.11.011","article-title":"Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow","author":"Mori","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.diabres.2022.110201_b0355","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14653240310003611","article-title":"Immunomodulatory effects of fetal and adult mesenchymal stem cells","volume":"5","author":"Le Blanc","year":"2003","journal-title":"Cytotherapy"},{"key":"10.1016\/j.diabres.2022.110201_b0360","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.diabres.2022.110201_b0365","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1634\/stemcells.2005-0008","article-title":"Role for interferon-\u03b3 in the immunomodulatory activity of human bone marrow mesenchymal stem cells","volume":"24","author":"Krampera","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.diabres.2022.110201_b0370","doi-asserted-by":"crossref","DOI":"10.1002\/cbin.10188","article-title":"Comparison of different methods for the isolation of mesenchymal stem cells from umbilical cord matrix: proliferation and multilineage differentiation as compared to mesenchymal stem cells from umbilical cord blood and bone marrow","author":"Hua","year":"2014","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.diabres.2022.110201_b0375","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1742-481X.2007.00408.x","article-title":"Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats","volume":"5","author":"Kwon","year":"2008","journal-title":"Int Wound J"},{"key":"10.1016\/j.diabres.2022.110201_b0380","doi-asserted-by":"crossref","unstructured":"Chen L, Tredget EE, Wu PY, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One. 2008; 3:e1886.https:\/\/doi.org\/10.1371\/journal.pone.0001886.","DOI":"10.1371\/journal.pone.0001886"},{"key":"10.1016\/j.diabres.2022.110201_b0385","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/647107","article-title":"Transplantation of bone marrow-derived mesenchymal stem cells promotes delayed wound healing in diabetic rats","author":"Wan","year":"2013","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.diabres.2022.110201_b0390","doi-asserted-by":"crossref","DOI":"10.1117\/1.3042266","article-title":"Bioimaging assessment and effect of skin wound healing using bone-marrow-derived mesenchymal stromal cells with the artificial dermis in diabetic rats","volume":"13","author":"Inoue","year":"2008","journal-title":"J Biomed Opt"},{"key":"10.1016\/j.diabres.2022.110201_b0395","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.2337\/db12-1822","article-title":"Topical administration of allogeneic mesenchymal stromal cells seeded in a collagen scaffold augments wound healing and increases angiogenesis in the diabetic rabbit ulcer","volume":"62","author":"O'Loughlin","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.110201_b0400","doi-asserted-by":"crossref","DOI":"10.3727\/096368912X657495","article-title":"Neurotrophin-3 accelerates wound healing in diabetic mice by promoting a paracrine response in mesenchymal stem cells","author":"Shen","year":"2013","journal-title":"Cell Transplant"},{"key":"10.1016\/j.diabres.2022.110201_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2012.09.022","article-title":"The effect of heme oxygenase-1 complexed with collagen on MSC performance in the treatment of diabetic ischemic ulcer","author":"Hou","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.diabres.2022.110201_b0410","doi-asserted-by":"crossref","DOI":"10.1038\/labinvest.2010.86","article-title":"Modifed multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice","author":"Amin","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.diabres.2022.110201_b0415","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jdiacomp.2014.05.003","article-title":"Mesenchymal stem cells ameliorate impaired wound healing through enhancing keratinocyte functions in diabetic foot ulcerations on the plantar skin of rats","volume":"28","author":"Kato","year":"2014","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabres.2022.110201_b0420","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/1534734615569053","article-title":"Mesenchymal stem cell conditioned medium improves the proliferation and migration of keratinocytes in a diabetes-like microenvironment","volume":"14","author":"Li","year":"2015","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.diabres.2022.110201_b0425","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1089\/ten.2006.0278","article-title":"Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds","volume":"13","author":"Falanga","year":"2007","journal-title":"Tissue Eng"},{"key":"10.1016\/j.diabres.2022.110201_b0430","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2217\/rme-2015-0045","article-title":"Delivery of mesenchymal stem cells in biomimetic engineered scaffolds promotes healing of diabetic ulcers","volume":"11","author":"Assi","year":"2016","journal-title":"Regen Med"},{"key":"10.1016\/j.diabres.2022.110201_b0435","unstructured":"Lamiaa M, Shawky, Eman A, El Bana, Ahmed A, Morsi. Stem cells and metformin synergistically promote healing in experimentally induced cutaneous wound injury in diabetic rats. Folia Histochem Cytobiol. 2019; 57:127-38. 10.5603\/FHC.a2019.0014."},{"key":"10.1016\/j.diabres.2022.110201_b0440","first-page":"1","article-title":"Regulation of inflammatory microenvironment using a self-healing hydrogel loaded with BM-MSCs for advanced wound healing in rat diabetic foot ulcers","volume":"31","author":"Bai","year":"2020","journal-title":"J Tissue Eng"},{"key":"10.1016\/j.diabres.2022.110201_b0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5021\/ad.2014.26.1.1","article-title":"Synergistic effect of bone marrow-derived mesenchymal stem cells and platelet-rich plasma in streptozotocin-induced diabetic rats","volume":"26","author":"Lian","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.diabres.2022.110201_b0450","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jphotobiol.2018.03.010","article-title":"Stereological and molecular studies on the combined effects of photobiomodulation and human bone marrow mesenchymal stem cell conditioned medium on wound healing in diabetic rats","volume":"182","author":"Amini","year":"2018","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.diabres.2022.110201_b0455","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/pho.2018.4453","article-title":"Effects of Photobiomodulation on Degranulation and Number of Mast Cells and Wound Strength in Skin Wound Healing of Streptozotocin-Induced Diabetic Rats","volume":"36","author":"Bagheri","year":"2018","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.diabres.2022.110201_b0460","doi-asserted-by":"crossref","unstructured":"Fridoni M , kouhkheil R, Abdollhifar MA, Amini A , Ghatrehsamani M , Ghoreishi SK , Chien S , Bayat S , Bayat M. Improvement in infected wound healing in type 1 diabetic rat by the synergistic effect of photobiomodulation therapy and conditioned medium. J Cell Biochem. 2019; 120:9906-16. 10.1002\/jcb.28273.","DOI":"10.1002\/jcb.28273"},{"key":"10.1016\/j.diabres.2022.110201_b0465","doi-asserted-by":"crossref","first-page":"e0177533","DOI":"10.1371\/journal.pone.0177533","article-title":"The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice","volume":"12","author":"Tomas","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2022.110201_b0470","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.actbio.2020.03.035","article-title":"Mesenchymal stem cell-laden, personalized 3D scaffolds with controlled structure and fiber alignment promote diabetic wound healing","volume":"108","author":"Chen","year":"2020","journal-title":"Acta Biomater"},{"key":"10.1016\/j.diabres.2022.110201_b0475","first-page":"6227","article-title":"Autologous bone marrow mesenchymal stem cell transplantation for treatment of diabetic foot following amplification in vitro","volume":"13","author":"Chen","year":"2009","journal-title":"J Clin Rehabil Tissue Eng Res"},{"key":"10.1016\/j.diabres.2022.110201_b0480","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/rej.2009.0872","article-title":"Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells","volume":"12","author":"Dash","year":"2009","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.diabres.2022.110201_b0485","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1000-1948(08)60031-3","article-title":"Autologous transplantation of bone marrow mesenchymal stem cells on diabetic patients with lower limb ischemia","volume":"23","author":"Debin","year":"2008","journal-title":"J Med Coll PLA"},{"key":"10.1016\/j.diabres.2022.110201_b0490","first-page":"38","article-title":"The effect of autologous bone marrow-derived cells on healing chronic lower extremity wounds: results of a randomized controlled study","volume":"57","author":"Jain","year":"2011","journal-title":"Ostomy Wound Manage"},{"key":"10.1016\/j.diabres.2022.110201_b0495","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1742-1241.2011.02886.x","article-title":"Autologous stem cell therapy in the treatment of limb ischemia induced chronic tissue ulcers of diabetic foot patients","volume":"66","author":"Kirana","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.diabres.2022.110201_b0500","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.diabres.2010.12.010","article-title":"Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial","volume":"92","author":"Lu","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2022.110201_b0505","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/0963689719835177","article-title":"Long-Term Outcomes of BMMSC Compared with BMMNC for Treatment of Critical Limb Ischemia and Foot Ulcer in Patients with Diabetes","volume":"28","author":"Lu","year":"2019","journal-title":"Cell Transplant"},{"key":"10.1016\/j.diabres.2022.110201_b0510","doi-asserted-by":"crossref","DOI":"10.1055\/s-2005-872886","article-title":"Locally applied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient","volume":"113","author":"Humpert","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.diabres.2022.110201_b0515","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1742-481X.2007.00349.x","article-title":"The use of marrow-derived stem cells to accelerate healing in chronic wounds","volume":"5","author":"Rogers","year":"2008","journal-title":"Int Wound J"},{"key":"10.1016\/j.diabres.2022.110201_b0520","doi-asserted-by":"crossref","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.diabres.2022.110201_b0525","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5966\/sctm.2011-0018","article-title":"Concise review: role of mesenchymal stem cells in wound repair","volume":"1","author":"Maxson","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.diabres.2022.110201_b0530","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/PRS.0b013e3182174329","article-title":"Bone marrow-derived mesenchymal stem cells enhanced diabetic wound healing through recruitment of tissue regeneration in a rat model of streptozotocin-induced diabetes","volume":"128","author":"Kuo","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.diabres.2022.110201_b0535","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/PRS.0b013e3181c722bb","article-title":"Mesenchymal stem cell therapy for nonhealing cutaneous wounds","volume":"125","author":"Hanson","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.diabres.2022.110201_b0540","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/stem.503","article-title":"Human gingiva-derived mesenchymal stem cells elicit polarization of M2 macrophages and enhance cutaneous wound healing","volume":"28","author":"Zhang","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.diabres.2022.110201_b0545","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"N\u00e9meth","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.diabres.2022.110201_b0550","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.diabres.2022.110201_b0555","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.2337\/db12-0145","article-title":"The role of MicroRNA-146a in the pathogenesis of the diabetic wound-healing impairment: correction with mesenchymal stem cell treatment","volume":"61","author":"Xu","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.110201_b0560","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/01.CIR.0000128213.96779.61","article-title":"Gene transfer of stromal cell-derived factor-1\u03b1 enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor\/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization","volume":"109","author":"Hiasa","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2022.110201_b0565","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/01.CIR.0000055313.77510.22","article-title":"Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization","volume":"107","author":"Yamaguchi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2022.110201_b0570","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cell.2005.10.036","article-title":"VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells","volume":"124","author":"Grunewald","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.diabres.2022.110201_b0575","doi-asserted-by":"crossref","first-page":"35544","DOI":"10.1074\/jbc.M608620200","article-title":"A novel class of vascular endothelial growth factor-responsive genes that require forkhead activity for expression","volume":"281","author":"Abid","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabres.2022.110201_b0580","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1095\/biolreprod.107.064477","article-title":"Activation of multiple signaling pathways is critical for fibroblast growth factor 2- and vascular endothelial growth factor-stimulated ovine fetoplacental endothelial cell proliferation","volume":"78","author":"Zheng","year":"2008","journal-title":"Biol Reprod"},{"key":"10.1016\/j.diabres.2022.110201_b0585","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0163-7258(91)90034-J","article-title":"Angiogenesis in wound healing","volume":"52","author":"Arnold","year":"1991","journal-title":"J Pharmacol Ther"},{"key":"10.1016\/j.diabres.2022.110201_b0590","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1432-2277.2008.00742.x","article-title":"Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure","volume":"21","author":"Li","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.diabres.2022.110201_b0595","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3346\/jkms.2011.26.6.726","article-title":"Mesenchymal stem cells improve wound healing in vivo via early activation of matrix metalloproteinase-9 and vascular endothelial growth factor","volume":"26","author":"Kim","year":"2011","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.diabres.2022.110201_b0600","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbrc.2009.05.010","article-title":"Profiling of anti-fibrotic signaling by hepatocyte growth factor in renal fibroblasts","volume":"385","author":"Schievenbusch","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.diabres.2022.110201_b0605","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/path.1578","article-title":"Diverse and potent activities of HGF\/SF in skin wound repair","volume":"203","author":"Bevan","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.diabres.2022.110201_b0610","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1165\/rcmb.2008-0217OC","article-title":"Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7","volume":"40","author":"Shukla","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.diabres.2022.110201_b0615","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1074\/jbc.M110.100388","article-title":"14S, 21R-dihydroxydocosahexaenoic acid remedies impaired healing and mesenchymal stem cell functions in diabetic wounds","volume":"286","author":"Tian","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabres.2022.110201_b0620","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.4049\/jimmunol.180.4.2581","article-title":"Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type","volume":"180","author":"Sasaki","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.diabres.2022.110201_b0625","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1524-475X.2007.00237.x","article-title":"Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells","volume":"15","author":"Javazon","year":"2007","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.diabres.2022.110201_b0630","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00441-007-0417-3","article-title":"Treatment of diabetic wounds with fetal murine mesenchymal stromal cells enhances wound closure","volume":"329","author":"Badillo","year":"2007","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.diabres.2022.110201_b0635","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/01.RES.0000074906.98021.55","article-title":"Leprdb diabetic mouse bone marrow cells inhibit skin wound vascularization but promote wound healing","volume":"92","author":"Stepanovic","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.diabres.2022.110201_b0640","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1634\/stemcells.2007-0941","article-title":"Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury","volume":"26","author":"Carvalho","year":"2008","journal-title":"Stem Cells"},{"issue":"217\u201331","key":"10.1016\/j.diabres.2022.110201_b0645","article-title":"On the origin and impact of mesenchymal stem cell heterogeneity: new insights and emerging tools for single cell analysis","volume":"34","author":"McLeod","year":"2017","journal-title":"Eur Cell Mater"},{"key":"10.1016\/j.diabres.2022.110201_b0650","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.5966\/sctm.2014-0109","article-title":"Clinical implication of allogenic implantation of adipogenic differentiated adipose-derived stem cells","volume":"3","author":"Kim","year":"2014","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.diabres.2022.110201_b0655","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1517\/14728222.2014.930440","article-title":"SDF-1 signaling: a promising target in rheumatic diseases","volume":"18","author":"Villalvilla","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.diabres.2022.110201_b0660","doi-asserted-by":"crossref","DOI":"10.1242\/dev.101071","article-title":"Chemokine signaling in development and disease","volume":"141","author":"Wang","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.diabres.2022.110201_b0665","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.actbio.2017.01.056","article-title":"Promoting tissue regeneration by modulating the immune system","volume":"15","author":"Julier","year":"2017","journal-title":"Acta Biomater"},{"key":"10.1016\/j.diabres.2022.110201_b0670","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/dmrr.2566","article-title":"Effect of osteopontin in regulating bone marrow mesenchymal stem cell treatment of skin wounds in diabetic mice","volume":"30","author":"Meng","year":"2014","journal-title":"Diabetes Metab Res Rev"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722010154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722010154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:24:28Z","timestamp":1759173868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722010154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":134,"alternative-id":["S0168822722010154"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110201","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow-derived mesenchymal stem cells: A promising therapeutic option for the treatment of diabetic foot ulcers","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110201"}}